Tandem Diabetes Care (TNDM) Inventory (2013 - 2026)

Tandem Diabetes Care's Inventory history runs 14 years deep, the most recent figure standing at $126.4 million for Q1 2026.

• Quarterly Inventory fell 10.46% year-over-year to $126.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.4 million (down 10.46% YoY) and the FY2025 annual result came in at $128.8 million, down 13.93% from the prior year.
• Inventory was $126.4 million for Q1 2026 at Tandem Diabetes Care, down from $128.8 million in the prior quarter.
• Across five years, Inventory topped out at $161.7 million in Q2 2024 and bottomed at $80.0 million in Q1 2022.
• A 5-year average of $132.8 million and a median of $141.2 million in 2025 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory jumped 67.54% — and 2025, when it declined 13.93%.
• Tandem Diabetes Care's Inventory stood at $111.1 million in 2022, then surged by 42.14% to $157.9 million in 2023, then declined by 5.27% to $149.6 million in 2024, then dropped by 13.93% to $128.8 million in 2025, then fell by 1.84% to $126.4 million in 2026.
• Business Quant data shows TNDM's Inventory at $126.4 million in Q1 2026, $128.8 million in Q4 2025, and $137.3 million in Q3 2025.